( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
4255.6
3826.8
3800.3
2984.5
Total Expenditure
5400
4179.9
4483.9
3083.8
PBIDT (Excl OI)
-1144.4
-353.09
-683.59
-99.30
Other Income
367.4
361
326.3
319.6
Operating Profit
-776.99
7.90
-357.3
220.3
Exceptional Items
NA
NA
NA
NA
PBDT
-809.79
-23.19
-386.6
193.5
Depreciation
135.7
117.3
104.1
92.9
Profit Before Tax
-945.49
-140.49
-490.7
100.6
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-1558.5
-142.59
-490.7
58.09
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-1558.5
-142.59
-490.7
58.09
Minority Interest
NA
NA
NA
NA
Shares of Associates
-53.1
-70
-102.6
-86.5
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-1611.6
-212.6
-593.3
-28.4
Equity Capital
1462.2
1446.1
1435.9
489.8
Calculated EPS
-1.10
-0.14
-0.41
-0.05
Calculated EPS (Annualised)
-4.40
-0.58
-1.65
-0.23
No of Public Share Holdings
1248818103
1152747069
1142539431
NA
% of Public Share Holdings
80.98
79.71
79.57
NA
PBIDTM% (Excl OI)
-26.89
-9.22
-17.98
-3.32
PBIDTM%
-18.25
0.20
-9.40
7.38
PBDTM%
-19.02
-0.60
-10.17
6.48
PBTM%
-22.21
-3.67
-12.91
3.37
PATM%
-36.62
-3.72
-12.91
1.94